https://vitalspanwire.com/news/sleep-study-ecg-model-predicts-heart-risksVitalspan Wireen2026-10-11T16:01:51.019ZSleep-study ECG model predicts later heart risks in hospital cohortshttps://vitalspanwire.com/news/aging-male-mice-lymph-nodes-t-cell-cancer-recognitionVitalspan Wireen2026-10-11T11:02:03.558ZStudy links shrinking lymph nodes to weaker cancer recognition in aging male micehttps://vitalspanwire.com/news/fda-approves-pritelivir-refractory-herpes-immunocompromised-adultsVitalspan Wireen2026-10-10T21:01:46.924ZFDA approves pritelivir for refractory herpes lesions in immunocompromised adultshttps://vitalspanwire.com/news/urolithin-a-trial-vascular-endpoint-brain-responseVitalspan Wireen2026-10-10T16:02:22.056ZUrolithin A trial finds no significant vascular benefit on primary endpointhttps://vitalspanwire.com/news/nopark-nicotinamide-riboside-parkinsons-clinical-outcomesVitalspan Wireen2026-10-10T11:01:31.048ZNicotinamide riboside fails to improve Parkinson outcomes in NOPARK trialhttps://vitalspanwire.com/news/survaxm-survive-glioblastoma-overall-survival-endpointVitalspan Wireen2026-10-09T21:01:38.042ZSurVaxM misses overall survival endpoint in glioblastoma trial